Upload Avatar (500 x 500)
Meifang Qi
mfqi@sinh.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Life Sciences
  • 2013-09 to 2019-01 PhD in Genetics: University of Chinese Academy of Sciences
  • 2009-09 to 2013-07 Bachelor's in Life Sciences: East China University of Science and Technology
  • 2024-01 to Present - Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences - Researcher
  • 2019-08 to 2023-11 - Massachusetts General Hospital, Harvard Medical School - Postdoctoral Researcher
  • Patent (2023): Low-cost assembly and analysis of core genome information based on epigenomic information, 2nd author, Patent No: CN110317856B
Integrating various omics data to analyze the impact of Y chromosome loss on cancer and clonal hematopoiesis
Analyzing molecular mechanisms of gender differences in cancer using genomic and transcriptomic data
Exploring new cancer treatment strategies and drug development
Developing computational methods for chromosome variation analysis using next-generation sequencing and single-cell sequencing
  • Loss of chromosome Y in primary tumors, Meifang Qi, 2023
  • Genomics of PDGFR-rearranged hypereosinophilic syndrome, Meifang Qi, 2023
  • cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries, Meifang Qi, 2021
  • Plant Regulomics: a data-driven interface for retrieving upstream regulators from plant multi-omics data, Meifang Qi, 2020
  • Polycomb repressive complex 2 attenuates ABA-induced senescence in Arabidopsis, Meifang Qi, 2019
  • CGT-seq: epigenome-guided de novo assembly of the core genome for divergent populations with large genome, Meifang Qi, 2018
  • GSHR, a Web-Based Platform Provides Gene Set-Level Analyses of Hormone Responses in Arabidopsis, Meifang Qi, 2018
  • Divergent regeneration‐competent cells adopt a common mechanism for callus initiation in angiosperms, Meifang Qi, 2017
  • CARMO: a comprehensive annotation platform for functional exploration of rice multi-omics data, Meifang Qi, 2015
Y Chromosome Loss Cancer Clonal Hematopoiesis Genomic Variation Transcriptomics Gender Differences Cancer Treatment Drug Development Next-Generation Sequencing Single-Cell Sequencing

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.